Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Jasna Banković · SciRah

Researcher profile · Semantic Scholar

Jasna Banković

Share profile

Jasna Banković — researcher profile on SciRah

h-index: 20
Works: 51
Citations: 1,027

Most-cited papers

Identification of genes associated with non-small-cell lung cancer promotion and progression.
Jasna Banković, J. Stojšić, D. Jovanović, Tijana Andjelković +3 more
2010Lung Cancer102 citations
Semantic Scholar
Elucidation and in planta reconstitution of the parthenolide biosynthetic pathway.
Qing Liu, David Manzano, N. Tanić, M. Pešić +7 more
2014Metabolic Engineering83 citations Open access
Semantic Scholar
The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines.
A. Podolski-Renić, Tijana Andelković, Jasna Banković, N. Tanić +2 more
2011Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie72 citations
Semantic Scholar
Targeting RAS-MAPK-ERK and PI3K-AKT-mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinoma.
Z. Milošević, M. Pešić, Tijana Stankovic, J. Dinić +5 more
2014Translational research : the journal of laboratory and clinical medicine53 citations
Semantic Scholar
Isolation and biological evaluation of jatrophane diterpenoids from Euphorbia dendroides.
I. Aljančić, M. Pešić, S. Milosavljević, Nina Todorović +9 more
2011Journal of Natural Products53 citations
Semantic Scholar
Synergistic effects of the purine analog sulfinosine and curcumin on the multidrug resistant human non-small cell lung carcinoma cell line (NCI-H460/R)
Tijana Andjelković, M. Pešić, Jasna Banković, N. Tanić +2 more
2008Cancer Biology & Therapy49 citations Open access
Semantic Scholar
Cytotoxic activity of sesquiterpene lactones from Inula britannica on human cancer cell lines
J. Fischedick, M. Pešić, A. Podolski-Renić, Jasna Banković +4 more
201343 citations
Semantic Scholar
Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma
M. Dragoj, Z. Milošević, Jasna Banković, N. Tanić +2 more
2016Cellular Oncology41 citations Open access
Semantic Scholar
Jatrophane diterpenoids from the latex of Euphorbia dendroides and their anti-P-glycoprotein activity in human multi-drug resistant cancer cell lines.
M. Jadranin, M. Pešić, I. Aljančić, S. Milosavljević +7 more
2013Phytochemistry41 citations
Semantic Scholar
The elimination of P-glycoprotein over-expressing cancer cells by antimicrobial cationic peptide NK-2: the unique way of multi-drug resistance modulation.
Jasna Banković, J. Andrä, N. Todorović, A. Podolski-Renić +6 more
2013Experimental Cell Research40 citations
Semantic Scholar
Identification of Novel Genetic Alterations in Samples of Malignant Glioma Patients
Vedrana P. Milinković, Jasna Banković, M. Rakic, Tijana Stankovic +3 more
2013PLoS ONE39 citations Open access
Semantic Scholar
New anti-cancer characteristics of jatrophane diterpenes from Euphorbia dendroides.
M. Pešić, Jasna Banković, I. Aljančić, Nina Todorović +8 more
2011Food and Chemical Toxicology39 citations
Semantic Scholar
New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer.
J. Dinić, A. Podolski-Renić, Tijana Stankovic, Jasna Banković +1 more
2015Current pharmaceutical design36 citations Open access
Semantic Scholar
Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing
A. Podolski-Renić, M. Jadranin, Tijana Stankovic, Jasna Banković +9 more
2013Cancer Chemotherapy and Pharmacology36 citations
Semantic Scholar
A perspective view on the nanomotion detection of living organisms and its features
L. Venturelli, A. Kohler, P. Stupar, M. I. Villalba +13 more
2020Journal of Molecular Recognition34 citations Open access
Semantic Scholar
Coalterations of p53 and PTEN tumor suppressor genes in non-small cell lung carcinoma patients.
Tijana Andjelković, Jasna Banković, J. Stojšić, Vedrana P. Milinković +3 more
2011Translational Research: The Journal of Laboratory and Clinical Medicine30 citations
Semantic Scholar
Genomic instability and p53 alterations in patients with malignant glioma.
Vedrana P. Milinković, Jasna Banković, M. Rakic, N. Milosevic +8 more
2012Experimental and molecular pathology (Print)28 citations
Semantic Scholar
Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma
Z. Milošević, Jasna Banković, J. Dinić, Chrisiida Tsimplouli +8 more
2018Cellular Oncology26 citations Open access
Semantic Scholar
DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P‐glycoprotein overexpressing cancer cells
A. Podolski-Renić, Jasna Banković, J. Dinić, Carla Ríos-Luci +6 more
2017European Journal of Pharmaceutical Sciences21 citations Open access
Semantic Scholar
Association of Overexpressed MYC Gene with Altered PHACTR3 and E2F4 Genes Contributes to Non-small Cell Lung Carcinoma Pathogenesis
M. Dragoj, Jasna Banković, A. Podolski-Renić, Sonja Stojković Burić +3 more
2019Journal of Medical Biochemistry20 citations Open access
Semantic Scholar
Positioning Europe for the EPITRANSCRIPTOMICS challenge
M. Jantsch, A. Quattrone, M. O'Connell, M. Helm +56 more
2018RNA Biology20 citations Open access
Semantic Scholar
Development of resistance to antiglioma agents in rat C6 cells caused collateral sensitivity to doxorubicin.
S. Stojković, A. Podolski-Renić, J. Dinić, Tijana Stankovic +6 more
2015Experimental Cell Research17 citations
Semantic Scholar
Association of CCND1 overexpression with KRAS and PTEN alterations in specific subtypes of non-small cell lung carcinoma and its influence on patients’ outcome
M. Dragoj, Z. Milošević, Jasna Banković, J. Dinić +3 more
2015Tumor Biology16 citations
Semantic Scholar
Comparative analyses of individual and multiple alterations of p53, PTEN and p16 in non-small cell lung carcinoma, glioma and breast carcinoma samples.
Tijana Stankovic, Vedrana P. Milinković, Jasna Banković, J. Dinić +3 more
2014Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie10 citations
Semantic Scholar
Anti-invasive effects of CXCR4 and FAK inhibitors in non-small cell lung carcinomas with mutually inactivated p53 and PTEN tumor suppressors
M. Dragoj, Jasna Banković, Evangelia Sereti, S. J. Stojanov +3 more
2017Investigational new drugs9 citations
Semantic Scholar
Sulfinosine enhances doxorubicin efficacy through synergism and by reversing multidrug resistance in the human non-small cell lung carcinoma cell line (NCI-H460/R)
M. Pešić, Tijana Andjelković, Jasna Banković, I. Marković +2 more
2009Investigational new drugs9 citations
Semantic Scholar
Purine nucleoside analogs in the therapy of cancer and neuroinflammation
D. Savic, Tijana Stankovic, I. Lavrnja, A. Podolski-Renić +6 more
20158 citations Open access
Semantic Scholar
Concurrent alteration of p16 and PTEN tumor suppressor genes could be considered as potential molecular marker for specific subgroups of NSCLC patients
Tijana Andjelković, Jasna Banković, Z. Milošević, J. Stojšić +4 more
2011Cancer Biomarkers8 citations Open access
Semantic Scholar
1085 Identification of altered genes associated with non-small cell lung cancer promotion and progression
Jasna Banković, J. Stojšić, S. Ruždijić, N. Tanić
20098 citations
Semantic Scholar
Decreased TSPAN14 Expression Contributes to NSCLC Progression
M. Jovanović, Tijana Stankovic, Sonja Stojković Burić, Jasna Banković +4 more
2022Life7 citations Open access
Semantic Scholar
Frontiers in Anti-Cancer Drug Discovery;
Atta-ur-rahman, M. Choudhary, A. Raza, A. Cavagis +34 more
20187 citations Open access
Semantic Scholar
Genetic alterations in quadruple malignancies of a patient with multiple sclerosis: their role in malignancy development and response to therapy.
Z. Milošević, N. Tanić, Jasna Banković, Tijana Stankovic +8 more
2014International Journal of Clinical and Experimental Pathology7 citations
Semantic Scholar
Simple avarone mimetics as selective agents against multidrug resistant cancer cells.
Marko Jeremić, M. Pešić, J. Dinić, Jasna Banković +3 more
2016European journal of medicinal chemistry5 citations Open access
Semantic Scholar
Prolonged survival after neoadjuvant chemotherapy related with specific molecular alterations in the patients with nonsmall-cell lung carcinoma.
J. Stojšić, Tijana Stankovic, S. Stojković, Vedrana P. Milinković +5 more
2015Experimental and molecular pathology (Print)4 citations
Semantic Scholar
Targeted Anti-Cancer Therapy, Acquiring and Overcoming Multi-Drug Resistance
M. Pešić, Jasna Banković, N. Tanić
20142 citations Open access
Semantic Scholar
No-Modified Saquinavir is Equally Efficient Against Doxorubicin Sensitive and Resistant Non-Small Cell Lung Carcinoma Cells / MODIFIKOVANA KOVANA FORMA SAKVINAVIRA EFIKASNO SU PRIMI RA RAST ĆELIJA NESITNOĆELIJSKOG KARCINOMA PLUĆA RAZLIČITE OSETUIVOSTI NA DOKSORUBICIN
S. Mijatović, M. Pešić, M. Mojić, Jasna Banković +7 more
20132 citations Open access
Semantic Scholar
Chemosensitivity and survival of non-small cell lung carcinoma patients receiving neoadjuvant therapy depend on the expression of multidrug efflux transporters
Tijana Stankovic, J. Stojšić, M. Dragoj, Z. Milovanović +8 more
2019Journal of Molecular and Clinical Medicine1 citations Open access
Semantic Scholar
Title: New Approaches with Natural Product Drugs for Overcoming Multidrug Resistance in Cancer Short running title: Natural Products and Cancer MDR
J. Dinić, A. Podolski-Renić, Tijana Stankovic, Jasna Banković +1 more
20200 citations
Semantic Scholar
Monitoring cellular nanometric scale oscillations by AFM
S. Kasas, A. Kohler, V. Pfannenstill, G. Schütz +6 more
20190 citations
Semantic Scholar
1667PTargeting CXCR4 and FAK in non-small cell lung carcinomas with co-inactivated p53 and PTEN tumor suppressors
A. Podolski-Renić, M. Dragoj, S. Stojković, J. Dinić +6 more
20170 citations Open access
Semantic Scholar
Anti-cancer Drugs - Nature, Synthesis and Cell
Jasna Banković
20160 citations Open access
Semantic Scholar
Mutual regulation and targeting of multidrug resistance and cancer stem phenotype
A. Podolski-Renić, Z. Milošević, J. Dinić, Tijana Stankovic +2 more
20160 citations
Semantic Scholar
Loss of heterozygosity of PTEN in patients with non-small cell lung cancer treated and not treated with neoadjuvant chemotherapy
J. Stojšić, Vedrana P. Milinković, S. Stojković, J. Dinić +2 more
2013European Respiratory Journal0 citations
Semantic Scholar
1008 Characterization of Newly Established P-glycoprotein Over-expressing Multi-drug Resistant Human Cancer Cell Lines
A. Podolski-Renić, M. Pešić, Maria Chiourea, Jasna Banković +5 more
20120 citations Open access
Semantic Scholar
934 NK-lysin Derived Peptide (NK-2) Sensitizes Resistant Cancer Cells to Classic Chemotherapeutics by Selective Killing of P-glycoprotein Over-expressing Cells
M. Pešić, Jasna Banković, A. Podolski-Renić, Z. Milošević +3 more
20120 citations
Semantic Scholar
Analysis of Genomic Instability and Tumor-Specific Genetic Alterations by Arbitrarily Primed PCR
N. Tanić, Jasna Banković, Nasta Tanić
20120 citations Open access
Semantic Scholar
Abstract B2: Alterations of p53, PTEN, and EGFR genes in glioblastoma multiforme
Jasna Banković, Vedrana P. Milinković, M. Rakic, M. Joković +4 more
20100 citations
Semantic Scholar
Abstract B42: Molecular and cytogenetic characterization of novel multidrug-resistant human tumor cell lines
S. Ruždijić, A. Podolski-Renić, M. Pešić, Maria Chiourea +5 more
20100 citations
Semantic Scholar
Abstract B55: The impact of inactivation of p53 and PTEN tumor suppressors on promotion and progression of human non‐small cell lung carcinoma
Tijana Andjelković, Jasna Banković, Vedrana P. Milinković, A. Podolski +2 more
20090 citations
Semantic Scholar
363 POSTER Genomic instability in non-small cell lung cancer assessed by arbitrarily primed polymerase chain reaction
Jasna Banković, J. Stojšić, S. Žunić, I. Selaković +3 more
20070 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Tanić×36
Invite
N. Tanić — researcher profile on SciRah
M. Pešić×36
Invite
M. Pešić — researcher profile on SciRah
S. Ruždijić×19
Invite
S. Ruždijić — researcher profile on SciRah
A. Podolski-Renić×19
Invite
A. Podolski-Renić — researcher profile on SciRah

Tijana Stankovic

×19

Invite

Tijana Stankovic — researcher profile on SciRah

Vedrana P. Milinković×14

Invite

Vedrana P. Milinković — researcher profile on SciRah

Invite

J. Dinić — researcher profile on SciRah

Z. Milošević×13

Invite

Z. Milošević — researcher profile on SciRah

J. Stojšić×9

Invite

J. Stojšić — researcher profile on SciRah

Tijana Andjelković×9

Invite

Tijana Andjelković — researcher profile on SciRah

Invite

M. Dragoj — researcher profile on SciRah

S. Stojković×6

Invite

S. Stojković — researcher profile on SciRah